RU2001124058A - ANTI-VIRAL MEDICINE AGAINST "AIDS" - Google Patents

ANTI-VIRAL MEDICINE AGAINST "AIDS" Download PDF

Info

Publication number
RU2001124058A
RU2001124058A RU2001124058/14A RU2001124058A RU2001124058A RU 2001124058 A RU2001124058 A RU 2001124058A RU 2001124058/14 A RU2001124058/14 A RU 2001124058/14A RU 2001124058 A RU2001124058 A RU 2001124058A RU 2001124058 A RU2001124058 A RU 2001124058A
Authority
RU
Russia
Prior art keywords
aids
blocking
same
medicine against
cobalt ions
Prior art date
Application number
RU2001124058/14A
Other languages
Russian (ru)
Inventor
Джорж Федорович Ливадный
Любовь Васильевна Медведева
Ромэо Гургенович Аршакуни
Original Assignee
Джорж Федорович Ливадный
Любовь Васильевна Медведева
Ромэо Гургенович Аршакуни
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Джорж Федорович Ливадный, Любовь Васильевна Медведева, Ромэо Гургенович Аршакуни filed Critical Джорж Федорович Ливадный
Priority to RU2001124058/14A priority Critical patent/RU2001124058A/en
Publication of RU2001124058A publication Critical patent/RU2001124058A/en

Links

Landscapes

  • Magnetic Treatment Devices (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Claims (3)

1. Способ лечения СПИДа, включающий принцип блокирования отрицательно заряженного вируса "СПИД" положительно заряженным белковым веществом в присутствии ионов кобальта (B12), отличающийся тем, что в качестве блокирующего вещества используют кровезаменители на основе тетрафторэтилена с положительными ионами кобальта (B12) с или без придания системе положительного статического заряда.1. A method of treating AIDS, including the principle of blocking a negatively charged AIDS virus with a positively charged protein substance in the presence of cobalt ions (B 12 ), characterized in that blood substitutes based on tetrafluoroethylene with positive cobalt ions (B 12 ) are used as a blocking substance or without giving the system a positive static charge. 2. То же, что и в п.1 совмещают с белками гликопротеина (Ср 41-120-160).2. The same as in claim 1 is combined with glycoprotein proteins (Cp 41-120-160). 3. То же, что и в п.1, и дополнительно вводят в систему ферромагнитные ионы железа, известные в качестве проводников СВЧ-изменений, воздействие которых в этих условиях приводят к селективному разрушению вируса СПИДа без нанесения вреда организму.3. The same as in claim 1, and additionally ferromagnetic iron ions are introduced into the system, known as conductors of microwave changes, the effect of which under these conditions leads to the selective destruction of the AIDS virus without harming the body.
RU2001124058/14A 2001-08-29 2001-08-29 ANTI-VIRAL MEDICINE AGAINST "AIDS" RU2001124058A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2001124058/14A RU2001124058A (en) 2001-08-29 2001-08-29 ANTI-VIRAL MEDICINE AGAINST "AIDS"

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2001124058/14A RU2001124058A (en) 2001-08-29 2001-08-29 ANTI-VIRAL MEDICINE AGAINST "AIDS"

Publications (1)

Publication Number Publication Date
RU2001124058A true RU2001124058A (en) 2003-06-10

Family

ID=35559572

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2001124058/14A RU2001124058A (en) 2001-08-29 2001-08-29 ANTI-VIRAL MEDICINE AGAINST "AIDS"

Country Status (1)

Country Link
RU (1) RU2001124058A (en)

Similar Documents

Publication Publication Date Title
EA200400632A1 (en) EFFECTIVE PEPTIDES IN THE TREATMENT OF TUMORS AND OTHER DISEASES THAT REQUIRE REMOVAL OR DESTRUCTION OF CELLS
WO2003008443A3 (en) Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
DE3787002D1 (en) SYNTHETIC PEPTIDES THAT GENERATE CELLULAR IMMUNITY AGAINST THE AIDS VIRUS AND ITS PROTEINS.
ATE231549T1 (en) METHOD FOR PRESERVING INFECTIOUS RECOMBINING VIRUSES, VIRAL AQUEOUS SUSPENSION AND MEDICAL USE THEREOF
ATE526019T1 (en) METHOD FOR TREATING CELL PROLIFERATION DISORDERS AND VIRUS INFECTIONS
DK0862633T3 (en) VP antigen of JC virus
WO2002000242A8 (en) Human papilloma virus treatment
DE60239394D1 (en) ONCOLYTIC VIRUS THERAPY
DK1096972T3 (en) Treatment using oriented unidirectional DC magnetic field
DE60009146D1 (en) PHARMACEUTICAL PREPARATIONS FOR TREATING DNA VIRAL INFECTIONS, WHICH CONTAIN A LOOP DIURETIC AND A HEART GLYCOSIDE
EA200001124A1 (en) METHOD OF GENE THERAPY
RU2001124058A (en) ANTI-VIRAL MEDICINE AGAINST "AIDS"
DE69733664D1 (en) Method of inactivating viruses and lyophilizing blood proteins
CA2370098A1 (en) Human beta-trcp protein
NO945031D0 (en) Use of a hymenopteran drug to prepare a drug for the treatment of DNA virus infections
DE3767731D1 (en) PROSTACYCLINANALOG, THIS AGENT CONTAINING IT AS AN ACTIVE COMPONENT, IMPROVING THE CIRCULATION OF THE BLOOD, AND AGENT AGAINST STOMACH.
ATE306275T1 (en) PHARMACEUTICAL PREPARATIONS FOR TREATING DNA OF VIRAL INFECTIONS, WHICH CONTAIN A LOOP DIURETIC AND LITHIUM
ATE544453T1 (en) COMBINATION THERAPIES WITH L-FMAU FOR THE TREATMENT OF HEPATITIS B VIRUS INFECTIONS
ATE192163T1 (en) PEPTIDES, ANALOGUES AND THEIR MIXTURES FOR THE DETECTION AND GENERATION OF ANTIBODIES AGAINST THE E1 AND E2 PROTEINS OF THE RUBELLA VIRUS
WO2002084294A3 (en) Gastrointestinal glutathione peroxidase in hepatitis c virus infections
ATE246930T1 (en) TREATMENT OF CHRONIC VIRAL INFECTION WITH M. VACCAE
EP1714979A3 (en) Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
RU2001106169A (en) METHOD FOR TREATING SARCOIDOSIS
WO1997008309A3 (en) Ribozyme therapy for hepatitis b infections
SE8902249D0 (en) DEVICE FOR BLOOD TREATMENT BY ELECTROMAGNETIC FIELDS AND DIALYSIS FILTERS

Legal Events

Date Code Title Description
FA93 Acknowledgement of application withdrawn (no request for examination)

Effective date: 20050111